Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026 2026-05-31 08:09
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet 2026-05-31 08:00
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet 2026-05-30 22:01
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO 2026-05-30 21:51
Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer 2026-05-29 20:52
The 3rd TÜV Rheinland Quality Fest Officially Kicks Off 2026-05-29 19:56
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting 2026-05-29 00:02
Fox ESS Announces Its Rebrand Ahead of SNEC Exhibition, Unveiling A New Brand Journey 2026-05-28 19:23
Axi Brings Award-Winning Funded Trading Program and Manchester City Partnership to FMAS:26 in Cape Town 2026-05-28 17:00
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test 2026-05-28 06:00
Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer 2026-05-27 18:40
Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List 2026-05-27 17:43
Kazia Therapeutics Expands Ongoing Phase 1b Trial of Paxalisib in Advanced Breast Cancer 2026-05-26 19:30
Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session 2026-05-26 12:35
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting 2026-05-25 18:56
Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations 2026-05-22 11:30
Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026 2026-05-22 08:00
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting 2026-05-22 05:34
Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026 2026-05-22 05:00
Fox ESS Celebrates Strong Momentum with Integrated Solar Storage & Charging Solutions at Smart Energy 2026 2026-05-09 10:17
1 2 3 4 5 7